Semler Scientific Inc. operates in the healthcare sector within the medical devices and diagnostic technology industry. The company develops noninvasive solutions for the detection and management of cardiovascular conditions.

Its main areas of activity include:

• Noninvasive diagnostic systems for vascular disease.
• Integration of software and hardware for clinical assessment.
• Data analytics applied to medical decision-making.
• Licensing and service-based healthcare solutions.

Semler Scientific focuses on technologies designed to improve early detection of peripheral vascular disease, supporting clinicians with scalable and efficient diagnostic tools.

Industry dynamics affecting the company include aging demographics, increasing prevalence of cardiovascular diseases, demand for early diagnostics, healthcare digitalization, reimbursement policies and competition in medical technology.

Shares of Semler Scientific Inc. trade on the Nasdaq under the ticker SMLR.

History and Development

Semler Scientific was founded in 2007 with the objective of developing noninvasive diagnostic technologies for cardiovascular conditions.

In its early years, the company focused on clinical validation, regulatory approval and building credibility among healthcare providers. Growth was driven by continuous improvement of its diagnostic platforms, expansion within primary care settings and the development of recurring revenue models based on licensing and services.

In 2014, the company completed its initial public offering (IPO), enabling further investment in technology and commercial expansion. Over time, Semler Scientific enhanced its product capabilities and strengthened integration with digital clinical workflows.

In recent years, the company has operated in an environment shaped by evolving healthcare practices, regulatory requirements and increasing demand for technology-driven diagnostics.

Additional Information

Semler Scientific Inc (United States) is listed on the Nasdaq and has a market capitalization of $304.95 million, with shareholders equity totaling $459.75 million.

The company employs approximately 79 people and operates in the Others sector, within the Others industry.

Over the past 12 months, Semler Scientific Inc reported $36.96 million in revenue, generating net income of $48.34 million.

Key financial metrics include a P/E ratio of 6.31, a price-to-book (P/B) ratio of 0.66, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SMLR.